WRF
HALO icon

Waddell & Reed Financial’s Halozyme HALO Stock Holding History

Waddell & Reed Financial’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		$19.9M Sell
476,681
-516,285
-52% -$23.6M 0.04% 367
2020
Q4 		$42.4M Sell
992,966
-327,752
-25% -$11.8M 0.09% 252
2020
Q3 		$34.7M Buy
1,320,718
+270,052
+26% +$7.52M 0.08% 266
2020
Q2 		$28.2M Buy
+1,050,666
New +$23.7M 0.07% 279

Other funds holding HALO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Waddell & Reed Financial's HALO Position: Q1 2021 in Review

Waddell & Reed Financial reduced its Halozyme (HALO) stake by 52% in Q1 2021, selling an estimated $23.6M and leaving 476,681 shares worth $19.9M. The position accounts for 0.04% of the portfolio, ranked #367.

Waddell & Reed Financial first reported a position in HALO in Q2 2020 and has held it in 4 quarters since. The position peaked at $42.4M in Q4 2020. 336 funds tracked by Wall St. Rank hold HALO as of Q1 2021.

  • Waddell & Reed Financial held 476,681 shares of Halozyme worth $19.9M as of Q1 2021.
  • Waddell & Reed Financial sold 516,285 Halozyme shares in Q1 2021, an estimated $23.6M.
  • Halozyme made up 0.04% of Waddell & Reed Financial's portfolio in Q1 2021, its #367 holding.
  • Waddell & Reed Financial first reported a position in Halozyme in Q2 2020 and has held it in 4 quarters since.
  • Waddell & Reed Financial's Halozyme position peaked at $42.4M in Q4 2020.
  • 336 funds tracked by Wall St. Rank held Halozyme as of Q1 2021.

Based on Waddell & Reed Financial's 13F filing for Q1 2021, filed 12 May 2021.